<p>This study aimed to examine Antiretroviral Therapy (ART) adherence and beliefs about medications among People Living with HIV (PLHIV) in Amman, Jordan. A cross-sectional study was conducted at the Almashora Health Center for AIDS patients from December 2022 to February 2023, with participants diagnosed with AIDS for at least six months recruited using convenience sampling. Medication adherence was assessed using the 4-Item Morisky Medication Adherence Scale, and beliefs about medications were evaluated with the Beliefs About Medication Questionnaire. A total of 180 PLHIV were recruited. Among them, 42.2% (<i>n</i> = 76) demonstrated low to moderate adherence, with an adherence score of ≤ 75%. The most frequent reason for non-adherence was being careless about medication timing (<i>n</i> = 60, 33.3%). Ordinal regression analysis revealed that higher educational levels (OR = 2.10, <i>p</i> = 0.03) and stronger perceptions of medication necessity (OR = 1.35, <i>p</i> &lt; 0.01) were positively associated with better adherence. Conversely, increased concerns about medications (OR = 0.73, <i>p</i> &lt; 0.01) were negatively associated with adherence. These findings indicate suboptimal ART adherence among PLHIV in Jordan. Higher concerns about medication side effects and lower educational levels were significantly associated with non-adherence. Targeted interventions that address patients’ concerns about ART and enhance medication-related education may improve adherence and health outcomes in this population.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Medication Adherence and Beliefs about HIV Treatment in Jordan: A Cross-Sectional Analysis

  • Sara Al-Ajlouny,
  • Tareq L. Mukattash,
  • Anan S. Jarab,
  • Walid Al-Qerem,
  • Omar M. Khalifeh,
  • Yazid Alhamarneh,
  • Rana K. Abu-Farha

摘要

This study aimed to examine Antiretroviral Therapy (ART) adherence and beliefs about medications among People Living with HIV (PLHIV) in Amman, Jordan. A cross-sectional study was conducted at the Almashora Health Center for AIDS patients from December 2022 to February 2023, with participants diagnosed with AIDS for at least six months recruited using convenience sampling. Medication adherence was assessed using the 4-Item Morisky Medication Adherence Scale, and beliefs about medications were evaluated with the Beliefs About Medication Questionnaire. A total of 180 PLHIV were recruited. Among them, 42.2% (n = 76) demonstrated low to moderate adherence, with an adherence score of ≤ 75%. The most frequent reason for non-adherence was being careless about medication timing (n = 60, 33.3%). Ordinal regression analysis revealed that higher educational levels (OR = 2.10, p = 0.03) and stronger perceptions of medication necessity (OR = 1.35, p < 0.01) were positively associated with better adherence. Conversely, increased concerns about medications (OR = 0.73, p < 0.01) were negatively associated with adherence. These findings indicate suboptimal ART adherence among PLHIV in Jordan. Higher concerns about medication side effects and lower educational levels were significantly associated with non-adherence. Targeted interventions that address patients’ concerns about ART and enhance medication-related education may improve adherence and health outcomes in this population.